10967/261 - QDB Compounds

QsarDB Repository

Zukić, S.; Osmanović, A.; Harej, A.; Kraljević Pavelić, S.; Špirtović-Halilović, S.; Veljović, E.; Roca, S.; Trifunović, S.; Završnik, D.; Maran, U. Data driven modelling of substituted pyrimidine and uracil-based derivatives validated with newly synthesized and antiproliferative evaluated compounds. Int. J. Mol. Sci. 2024, 25, 9390

Compound

ID:T39
Name:CHEMBL244769
Description:
Labels:Train
CAS:
InChi Code:InChI=1S/C37H34N2O6/c1-2-3-6-11-27-16-18-28(19-17-27)20-21-31-24-39(37(42)38-35(31)40)23-22-32-33(43-25-29-12-7-4-8-13-29)34(36(41)45-32)44-26-30-14-9-5-10-15-30/h4-5,7-10,12-19,22,24H,2-3,6,11,23,25-26H2,1H3,(H,38,40,42)/b32-22-

Properties

pIC50: Antiproliferative activity [-log(uM)] i

ValueSource or prediction
5.52

Gazivoda, T.; Šokčević, M.; Kralj, M.; Šuman, L.; Pavelić, K.; De Clercq, E.; Andrei, G.; Snoeck, R.; Balzarini, J.; Mintas, M.; Raić-Malić, S. Synthesis and Antiviral and Cytostatic Evaluations of the New C-5 Substituted Pyrimidine and Furo[2,3-d]pyrimidine 4‘,5‘-Didehydro-L-ascorbic Acid Derivatives. Journal of Medicinal Chemistry 2007, 50, 4105–4112. http://dx.doi.org/10.1021/jm070324z

4.90674

Eq.1: QSAR model for for antiproliferative activity for HeLa cells (Training set)